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INTRODUCTION 
Fever is one of the commonest manifestations of 
immunity and hypersensitivity. Although many aspects of 
hypersensitivity reactions have been exhaustively studied, 
the mechanisms by which immune processes produce fever, 
and the relationship of fever to immune phenomena have been 
the subject of only few investigations. This research 
project was undertaken to investigate the possibility that 
pyrogen production by mononuclear blood cells could result 
from interaction of cells with antigen-antibody complexes. 
Mononuclear cells from peripheral blood of human volunteers 
were chosen for this study, since methods are available 
for isolation of these cells, and the monocyte is known 
to be a pyrogen-producing cell (1), In addition, monocytes 
are the probable precursors of most tissue macrophages, 
cells which are known to interact with antibody and antigen- 
antibody complexes, both in. vivo and in. vitro, and which 
may plav an important role in immune fever. No previous 
in vitro studies have demonstrated pyrogen release from 
cells in response to antigen-antibody complexes. 
HISTORICAL BACKGROUND 
Endogenous Pyrogen 
Fever as a manifestation of disease has been well 
known for centuries, yet it is only in recent decades that 
the pathogenesis of this response has in part been elucidated. 
Although most commonly associated with diseases of infectious 
origin, it is also a manifestation of man*' diverse processes 
■ 
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associated with inflammatory states including neoplasia, 
hypersensitivity reactions, infarction and mechanical injury. 
Dickensen (2) recognized in 1785 that fever seemed to be 
brought about by the absorption of the products of the 
injured cells of a febrile animal. However, the demonstra¬ 
tion that fever is actually caused by factors derived from 
host cells was first accomplished when differentiation of 
"endogenous” or cell pyrogens could clearly be made from 
the endotoxins of gram negative bacteria. 
In 1948, Beeson (3) showed that cells, predominantly 
polymorphonuclear leukocytes, obtained from sterile, saline 
induced, peritoneal exudates, were capable of producing 
fever when injected into a normal rabbit. He showed, more¬ 
over, that a soluble fraction of such cells obtained by 
mechanical lysis was the responsible factor; cell debris 
was not pyrogenic. Earlier work by Billroth (4) in the 
19th century and by Fenkin (5) in 1943 had suggested that 
cells from purulent exudates released a soluble pyrogen, 
but these ^reparations were very likely contaminated with 
bacterial endotoxin, so the observed febrile responses 
were of indeterminate etiology (6). However, using tech¬ 
niques to avoid endotoxin contamination, Bennett and Beeson 
(6) surveved extracts of normal rabbit tissues for 
pyrogenicity and found that only peritoneal exudate cells 
and cells from Arthus and Schwartzman lesions were caoable 
of oroducinp febrile responses when injected into normal 
animals. This leukocyte oyrogen was shown to produce 
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fevers with a latent period of 10 to 15 minutes, and a 
peak response within one hour. The substance was heat 
labile and nondialyzable (7), Subsequent work has shown 
that the endogenous pyrogen molecule contains essential 
peptide bonds, has a molecular weight of 10,000 to 20,000 
and requires free SH groups for activity (8,9,10), Of 
great significance were the findings that febrile tolerance 
did not appear after repeated injections and that there was 
no cross tolerance in animals which were tolerant to the 
effects of bacterial pyrogens (11). The first evidence that 
such an endogenously produced mediator was present in the 
circulation of febrile animals and that it could clearly 
be distinguished from the bacterial pyrogen producing the 
fever was presented by .Atkins and Wood (12), They showed 
that, after injection of typhoid vaccine into rabbits, two 
different pyrogenic substances could be demonstrated in 
their serum. A pyrogen which was present in the serum 
gathered 5 minutes after typhoid injection, was inactive 
when injected into rabbits previously rendered tolerant 
to the vaccine. A pyrogen present in serum drawn at 2 
hours, however, when the animal was febrile, was active 
in both normal and tolerant animals. The early appearing 
pyrogen produced responses similar to those induced by 
bacterial pyrogens; the responses of the late appearing 
pyrogen was similar in character to that of leukocyte 
pyrogen. Furthermore, when tolerance to the typhoid vaccine 
in the recipient animals was reversed, febrile responsive- 
■ 
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ness to the exogenous pyrogen returned and could be 
correlated with the reappearance of endogenous pyrogen in 
the serum of the challenged animal. So it appeared that 
exogenous bacterial pyrogens produced fever indirectly by 
liberating from the cells of the host an 'endogenous 
pyrogen’ which effected changes in the thermoregulation of 
the host. Endogenous pyrogen was further differentiated 
from gram negative endotoxins on the basis of its full 
effects on animals rendered granulocytopenic and therefore 
relatively unresponsive to bacterial pyrogen infections (13), 
The endogenous pyrogen also was shown to have a potentiated 
effect when infused into the carotid artery, whereas intra¬ 
venous or intra-carotid infusion of bacterial pyrogen 
produced equivalent responses. Work by Cooper (14) had 
shown that integrated thermoregulatory changes were 
mediated by the action of endogenous pyrogen in the 
anterior hypothalamus; the carotid infusion of endogenous 
pyrogen therefore presented very high concentrations at its 
site of action. 
Endogenous pyrogen release from stimulated cells has 
been shown to be associated with the fever due to numerous 
other infectious agents. Gram positive bacteria appear to 
stimulate cells by a variety of mechanisms , including 
cellular actions of liberated toxins, phagocytosis of 
bacterial particles, and immune reactions. A variety of 
virus-induced fevers are associated with endogenous ovrogen 
release (15,16). Culture filtrates of various pathogenic 
. 
‘ 
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fungi (17), and a protein extract of cryptococci (18) appear 
to cause fever by inducing endogenous pyrogen production 
by host leukocytes, probably as a result of immune processes. 
Certain non-microbial substances have been shown to be 
pyrogenic. For example, some prostaglandins cause fever 
when applied directly to the hypothalamus (19); perhaps 
they function normally as intermediates in responses 
mediated by endogenous pyrogen. Steroids such as etio- 
cholanolone primarily act by inducing endogenous pyrogen 
release from cells (20), 
Endogenous pyrogen from cells of different species 
are variously pyrogenic in other species. While rabbit 
endogenous oyrogen is inactive in dogs, guinea pig and 
mouse cell pyrogens are active in rabbits (21). Of great 
experimental usefulness is the activity of human endogenous 
pyrogen in rabbits since this orovides an easy and reliable 
assay of human pyrogen (22). 
Mononuclear Cells as Parogen Producing Cells 
In early work by Bennett and Beeson (6,7) and by King 
and Wood (23), endogenous pyrogen was obtained from sterile 
exudates composed mainly of granulocytes. However, it was 
shown by Snell and Atkins (24) that small amounts of substance 
with activity indistinguishable from, that of granulocyte 
endogenous pyrogen could be extracted from homogenized, 
uninfected rabbit tissues such as muscle, lung, heart, 
soleen, liver and kidney. Neither endotoxin nor sequestered 
polymorphonuclear leukocytes could account ror the pyrogen 
. 
■ 
' 
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thus extracted. 
The first direct evidence that nononuclear cells could 
be a source of endogenous pyrogen production come from the 
work of Bodel et al_ (25). First, it was shown that blood 
from patients with agranulocytosis was capable of producing 
endogenous pyrogen when stimulated with heat killed 
Staphylococcus albus. Such blood ^reparations had 4 percent 
or less neutrophils by differential count. Incubation with 
staphylococci of numbers of polymorphonuclear leukocytes 
comparable to those in these blood preparations produced 
only minimal amounts of pyrogen. Similarly, blood from 
patients with monocytic and myelomonocvtic leukemia was 
capable of producing endogenous pyrogen when incubated with 
staphylococci. The numbers of contaminating granulocvtes 
were inadequate to account for the amount of pyrogen 
produced. Also, normal blood monocytes, isolated by their 
low densitv, through albumin density centrifugation, and 
by their propertv of sticking to glass surfaces, according 
to the observations of Bennett and Cohn (25), were found to 
produce endogenous pvrogen in response to phagocytosis of 
staphylococci. Again, contaminating granulocytes could not 
account for the observed activity. 
Hahn et al (27) showed that peritoneal macroohanes 
harvested from oil induced exudates in rabbits also could 
be a source of endogenous pyrogen. Pvrogen production by 
these cells could be distinguished from that of granulocytes 
by the macrophages' capacity to produce endogenous pvrogen 
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for periods of time significantly longer than was nossible 
for granulocytes•under the same incubation conditions. 
Further direct evidence linking monocytes and monocyte 
derived tissue macrophages was gathered by Atkins, Bodel 
and Francis (28) using tissues from rabbits previously 
sensitized to BCG (Bacillus Calmette-Guerin). Blood and 
lung macroohages when incubated with Old Tuberculin (O.T.) 
released amounts of pyrogen in proportion to the dose of 
O.T, present in the incubation mixture whereas spleen and 
lymph node preparations were entirely inactive. It was 
shown that more lung macrophages were required to produce 
an amount of pyrogen equal to that produced by a given 
number of blood leukocytes. They showed further that the 
lung macrophages were capable of continued endogenous 
pyrogen release even after the stimulus had been removed. 
These cells released little or nofpyrogen after five hours 
incubation, minimal amounts after eighteen hours, and greater 
amounts in a supportive medium (buffer plus glucose) than 
in just saline, a requirement not shown for granulocytes. 
However, it was observed that, like granulocytes the lung 
cells required incubation at 37°C and their pyrogen produc¬ 
tion was inhibited by blocking protein synthesis with 
puromvcin. That different activators may react with different 
tissues ^as demonstrated by the finding that spleen and 
lymph node preparations, while not responding to O.T., were 
capable of pyrogen release when stimulated bv phagocytosis 
of heat-killed staohvlococcus. In all of these studies it 
■ 
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was shown that the numbers of contaminating granulocytes 
were inadequate to account for the observed pyrogen release. 
Work by Dinarello et al (29) showed that a preparation 
of liver cells was active in pyrogen production in response 
to stimulation by O.T., heat killed staph and endotoxin. 
A separation of these cells into fractions of Kupfer cells 
and hepatocvtes and subsequent stimulation showed that the 
Kupfer cells were uniformly responsible for the observed 
activity. 
Human peripheral blood monocytes isolated according 
to the methods of Boyum (30) and incubated in tissue 
culture, have been shown to release pyrogen in response to 
endotoxin to heat killed staph and to tuberculin (Bodel, 
unpublished observations). This preparation of mononuclear 
cells represents a cell population remarkably free of 
contaminating polymorphonuclear leukocytes (less than 1%) 
and rendered moderately free of lymphocytes by allowing 
the monos to fix to the plastic surface of the tissue 
culture flask and then decanting the remaining medium con¬ 
taining the lvmphocvtes. . This is the monocyte system used 
in the experiments reported below. In no svsten has the 
lymphocyte, when free of other known pyrogen producing 
cells, been observed to release any pyrogenic substance (31). 
Moreover, the monocyte is a much more potent source of 
endogenous oyrogen than is the granulocvte. Unlike the 
lower potency of lung macrophages, oeripheral monocvtes 
have been shown to produce several fold greater amounts 
. 
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of pyrogen per given number of cells than do polymorpho¬ 
nuclear leukocytes when stimulated by etiocholanolone 
or when stimulated by phagocytosis of heat killed 
staphylococci (32). And, to date, no discernible differences 
had been noted in the pyrogenic response curve from a 
single injection nor in the shape of the dose response 
curve for monocytes as compared to polymorphonuclear 
leukocytes. 
It must be noted that monocytes placed in tissue 
culture undergo profound morphological and metabolic 
changes, transforming into macrophage-like cells, epithelioid 
cells and multinucleate giant cells (33,34,35). However, 
the time required for isolation of these cells and fixation 
to the tissue culture flasks is approximately 6 hours and 
while some transformation has been observed in such cells 
over such a time period, they are minimal. They include 
an increase in cytoplasmic pseudopodia, an increase in smooth 
endoplasmic reticulum, more numerous lysosomes, and the 
appearance of cvtoolasmic filaments (35). However, all of 
these changes are minimal, especially compared with the 
marked morphological changes occurring at times of 24 hours 
or more. Similarly, the most marked metabolic changes of 
the cells characteristically occur after 24 or 43 hours (34). 
So the pyrogen producing mononuclear cells in the oresent 
experiments are probably more like the peripheral blood 
monocyte than a well differentiated tissue macrophage. 
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Interactions between Mononuclear Cells and An 11 p e n - An 11 b o d v 
Complexes 
The first direct evidence that cells interact specificall 
with antibodv in such a way as to mediate the uptake of 
foreign antigen by mononuclear cells came from the work of 
Boyden and Sorkin (36) using a rabbit spleen cell prepara¬ 
tion. When these cells were treated with specific anti¬ 
sera to human serum albumin and then washed, they were 
capable of specifically adsorbing the antigen. Boyden (37) 
later demonstrated that peritoneal macrophages were the 
active receptor cells in such reactions, unlike oolvmor- 
phonuclear leukocytes or lymphocytes. Also he demonstrated 
that the reaction could occur with large ‘particulate’ 
antigens such as red blood cells. When serum from guinea 
pigs immunized with sheep red blood cells was mixed with 
guinea pig peritoneal macrophages, and sheep red cells were 
added, the red cells were specifically adsorbed and formed 
"rosettes" about the macrophages. 
That the interaction is specifically mediated by 
antibody is clear, since without soecificallv immune serum 
present there is no rosette formation (36), and there is 
negligible uptake of smaller antigens (38,39). Berken (40) 
showed that rosette formation with peritoneal macrophages 
occurred to a greater extent with cells from non-immune 
than from immune animals. And LoBuglio ewt al (41) noted 
sphering of D positive red cells, sensitized with anti-D 
antibodies, about leukocytes from either D positive or D 
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negative donors. Furthermore, Huber (42) had shov/n that 
red cells coated non-immunologically with immunoglobulins 
would form rosettes, and Arend and Mannik (39) showed that 
heat aggregated immunoglobulin could be bound to macro¬ 
phages. So the reaction is apparently mediated by anti¬ 
bodies . 
Berkin (40) demonstrated such a "cytophilic antibody" 
to E. coli polysaccharide. Huber et al (43) found similar 
results using isolated peripheral monocytes, hepatic 
macrophages, and a splenic macrophage preparation. However, 
he too observed that lymphocytes were not capable of such 
activity, even when stimulated with a variety of phyto¬ 
mitogens, However, subsequent data indicates that plate¬ 
lets (44), polymorphonuclear leukocytes (44), and B lymoho- 
cytes (45) have receptors for components of antigen-antibody 
complexes or complexes of antigen, antibody, and complement. 
Specific antibodv-mediated uptake of antigen by macrophages 
has been studied in several systems. Antigens include horse¬ 
radish peroxidase (38), heterologous protein antigens such 
as human serum albumin (39), and small polyvalent haptens 
(46). 
Only certain classes of immunoglobulins appear to 
function in mediating uptake. Berkin et al (40) noted that 
’cytophilic’ antibody for macrophages appeared at approxi- 
matelv the eighth day of immunization and further noted 
that it had a 7S sedimentation coefficient. He also noted 
that the active antibodies migrated along with other slow 
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migrating, complement fixing antibodies. Rabinovitch (47) 
shotted that globulins with a high sedimentation coefficient 
were inactive, unlike 7S fractions. In addition, treatment 
of the 7S antibodies with pepsin markedly diminished their 
binding properties. Similar results had been shown previously 
by Berkin et al (40). This finding irrralicates the Fc region 
of the antibody in the attachment reaction. Huber et a!L 
(42) showed that for peripheral blood mononuclear cells, 
IgM antibody failed to induce rosette formation, whereas 
IgG antibody was effective. Using purified myeloma anti¬ 
bodies of specific subclass, he showed that IgG-|_, and IgGg 
were most effective, while IgG2 and IgG-4 were least active. 
He showed further that pepsin digestion of the antibody 
partially reduced its activity, whereas papain digestion 
eliminated all binding activity. These findings were 
confirmed by Abramson et al_ (48) and LoBuglio et al (41). 
In several models, both rosette formation and uptake 
of soluble antigens was easily inhibited by free antibody 
Dresent in the reaction medium, in amounts equal to or less 
than those found normally in the plasma. For this reason, 
the relevance of the interactions observed in vitro between 
cells and antigen-antibody comnlexas to in. vivo events is 
not clear. However, other mechanisms seemed to play a role 
in producing the observed ohenomena. Huber et al (42) 
orooosed that interaction between cells and comolexes 
proceeded in two stems, first binding and then ohagocytosis. 
Thev noted, as had Berkin et al (40) that In order to 
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observe rosette formation, the reaction had to be carried 
out at room temoerature. At 37°C the red cells were readily 
phagocvtosed. And it became apparent that both binding and 
phagocytosis were in some way intimately tied to activity 
of the complement system. 
The role of complement in the attachment of Comdexes 
to cells has received much attention. Berkin et al (40) 
noted that rosette formation was not altered when the serum 
had been heated to 56°C, and Huber et al (42) showed that 
the reaction occurred in the absence of complement. However, 
in another series of experiments, using red cells coated 
with antibody alone or with antibody and complement, these 
authors observed that while binding and ingestion could 
occur in the absence of complement, the inhibitory effects 
of free IgG on binding were not observed when complement 
was present. They found that C3 was the active comdement 
component in this reaction, since cells coated only with 
Ci, C^_4 or C]_42 were not bound in the presence of free 
IgG, and addition of Cgg7 also did not enhance the inter¬ 
action. Since free IgG did not inhibit binding if added 
after red cell attachment had taken dace, it was concluded 
that the function of complement was to enhance the attach¬ 
ment, not the ingestion step. The authors further concluded 
that there was a separate complement "recentor" on the 
monocyte. Work by Mantovani et al (49) further confirmed 
such a role for comdement, showing, at least at low con- 
■ 
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centrations of red cell bound IgG, that the effect of 
was greater on the attachment phase than on the ingestion 
phase* They also noted that by adding anti-IgG to a system 
with no complement, ingestion of antibody coated erythrocytes 
was reduced more than attachment. They concluded that the 
role for the complement ’receptor’ was primarily for 
attachment and that the role for the IgG receptor was 
primarily for ingestion. However, Abramson et al (48), 
using cells coated with antibodies, and coated with C3 
but then washed free of antibody, observed that neither 
binding nor phagocytosis took place. Thus, no direct 
evidence for the existence of a separate, functional com¬ 
plement ’receotor’ was demonstrated. Furthermore, incomplete 
removal of antibodies from such complement coated cells 
resulted in some reosette formation. Nonetheless, comole- 
ment appears to enhance interactions of antibodv-coated 
particles and cells. It may act by altering the cell 
surface through its enzymatic activity (50,51), since 
pretreatment of monocvtes with various proteolvtic enzvm.es 
has been demonstrated to enhance both rosette formation 
(52) and uotake of soluble complexes (39). 
The importance of complement is not so clear, however, 
in experiments where adherence of soluble immune complexes 
has been studied. Arend and Mannik (75) noted that uotake 
of soluble, circulating complexes of HSA and rabbit anti- 
HSA by the liver occurred at the same rata in normal and 
in complement-depleted animals. In addition, complement 
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did not reverse the inhibiting effect of free IgG on the 
macrophage-antigen-antibody complex interactions in vitro. 
IgG in buffer inhibited the interaction as well as did IgG 
in serum. Complement-depleted serum containing free IgG 
inhibited adherence just as well as did serum containing 
complement. The authors postulate that the role of comple¬ 
ment in mediating interactions between mononuclear cells 
and soluble antigen-antibody complexes may be to potentiate 
phagocytosis, not adherence, perhaps by means of its peptidase 
activity. A number of factors have been shown to govern 
the uptake of non-particulate antigen-antibody complexes 
by mononuclear cells. The size and structural complexity of 
the•complexes, the total numbers of antibody-receptor 
interactions, and allosteric effects on the rc region 
induced by the antibody’s interaction with antigen all may 
have a role in determining the extent of binding of 
complexes to cells. 
Multiple antibody-receptor interactions are necessary 
for effective cellular uptake of soluble complexes. Phillips- 
Quagliata et al (46), in studies using monovalent, divalent, 
and polyvalent small haptens, measured the amount of binding 
of antibodv to macrophages, and the effects of each kind of 
antigen on that binding. They found that there was a great 
increase in binding of antibody to cells when the antibody 
and cells were reacted in the presence of polyvalent antigen 
in amounts comparable to an equivalence precipitation, 
There was a smaller increase in bound antibodv when divalent 
■ 
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antigen was added, and there was no increase when mono¬ 
valent antigen was present over a wide range of antigen 
concentrations. Furthermore, large excesses of mono- or 
divalent hasten blocked the uptake of antibody mediated by 
polyvalent antigen. They noted that binding was optimal in 
slight antibody excess with the polyvalent antigen. In 
extreme antigen excess, even with the polyvalent antigen, 
there was no uptake of antibody by the cells over the 
baseline level. Noting that free IgG almost completely 
inhibited binding, meaning that it already has an exposed 
site for binding with the receptor, the authors propose 
that it is primarily a summation of numerous antibody- 
recestor bindings which accounts for the specific attachment 
of structurallv complex antigen-antibody complexes, not 
allosteric effects of antigen on the antibody mediating 
a tighter binding between the receptor and the antibody’s 
Fc region, 
Arend and Mannik (39), however, by comparing the 
greater binding of soluble antigen-antibody complexes with 
that of aggregated IgG, concluded that efficiency of 
binding was not solely mediated by summation of individual 
binding sites. However, they also showed that large complexe 
of greater than IIS sedimentation coefficient selectively 
adhered to the nacroohases. Soluble complexes of IIS or less 
did not adhere as well, and these smaller complexes were 
determined to be a molecule of antigen with one or two 
molecules o^ antibody. The complexes which bound best were, 
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therefore, complexes containing at least one antigen molecule 
and at least two antibodies. This would seem to support Phillip- 
Quagliata's data showing that summation of binding sites 
interactions does play a role, but also shows that conforma¬ 
tional changes in the Fc region mediated by interaction with 
antigen may play a role in formation of a firm attachment 
between antibody and monocyte receptor, especially since 
large protein antigens produce greater conformational changes 
than small molecules (53). So it seems apparent then that 
interactions between antigen-antibody complexes and cells 
is not a simple one and may be a multiphase process which 
depends on various factors or combinations of factors such 
as cell type, size and structure of antigen, size and 
antigen-antibody ratio of immune complexes, complement 
mediated mechanisms, total number of interactions between 
antibody and receptor, and allosteric effects due to the 
antigen-antibody interaction itself. 
Experimental Immune Fever 
It has been suspected since early in this century that 
mechanisms of hypersensitivity could be responsible for fevers. 
The fever associated with known ’toxic' effects of microbes 
and their products, notably the endotoxin of Pram negative 
bacteria, were well known. However, it was postulated early 
in this century that the fever of certain infectious diseases 
might in fact be due to mechanisms of hypersensitivity (54). 
In 1964, Farr was first able to produce fevers using 
non-bacterial heterologous protein antigens injected into 
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specifically sensitized animals (55). He found after giving 
rabbits injections of 10 mg of bovine serum albumin (BSA) 
three times a week for 3 to 6 weeks, that approximately 70 
oercent of such animals would respond with fever when given a 
2 mg injection of the BSA. Numerous other antigens have 
proven to be pyrogenic when injected, including human serum 
albumin (HSA) (56), bovine gamma globulin (3GG) (57), and 
culture filtrates of staphylococcus (58), certain fungi, a 
protein extract of cryptococcus (18), Old Tuberculin (59), 
drugs such as Penicillin (60), and numerous other drugs 
(61). Febrile reactivity to some substances appears to be 
due to immediate humoral hypersensitivity, e.g. BSA (55) 
and HSA (56) and Penicillin (60), while others appear 
to be related to "delayed" hypersensitivity, e.g. staph 
(58); fever to tuberculin may be the result of a mixed 
response to a variety of antigen substances in the tuberculin 
preparation (62), 
That immune fever could be produced in states of 
"delayed" tyoe hypersensitivity had been clearly demonstrated 
when IJhr (63) and coworkers observed febrile responses in 
guinea pigs which had been sensitized with antigen-antibody 
complexes in antibody excess such that no circulating antibod 
was oresent, but in which the typical skin reactivity of 
delaved hypersensitivity was oresent. In the orocess of 
"desensitizing" such animals with a single large dose of 
antigen, Uhr observed that desoite the loss of local skin 
reactivity after the infection, there was a systemic resoonse 
N 
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which included fever, lymphopenia and a later secondary 
antibody response (64). 
It is of some minor interest that an alternative to 
an endogenous pyrogen mediated pathway, in the febrile response 
associated with delayed hypersensitivity states was proposed 
by Johanovsky (65). He claimed to be able to obtain by 
incubation of antigens such as tuberculin with mononuclear 
cells and cell extracts of hypersensitive animals the release 
of a pyrogen with response characteristics unlike that of 
endogenous pyrogen. It was a substance which could act with 
no latent period, which could, unlike endogenous pyrogen, 
be produced at 4°C and could be produced in the absence of 
intact cells. Work at Atkins and Heijn (66), however, did 
not corroborate these findings; rather it was shown that BCG 
(Bacillus Calmette-Guerin)-sensitized cells incubated in the 
presence of tuberculin released endogenous pyrogen. In 
addition, normal, i.e. non-sensitized, blood cells incubated 
in the plasma from sensitized animals would also release endo¬ 
genous pyrogen when stimulated by tuberculin in vitro. This 
implies that the fevers produced by tuberculin mav well have 
had an antigen-antibody mediated component, since mixtures 
of tuberculin with sensitized rabbit plasma in_ vitro did 
produce fever when injected into normal animals, and had 
the characteristic delayed response of other immune fevers. There 
is more recent evidence for fever production mechanisms 
unrelated to the formation of antigen-antibody complexes 
delayed hypersensitivity. In an effort to study fever in 
m 
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"pure” delayed hypersensitivity, Atkins et al sensitized 
rabbits to various heterologous proteins and protein hapten 
conjugates and studied pyrogen production in vitro by 
various tissues in the presence of the conjugate and carrier. 
This was done at a time when negligible amounts of precipi¬ 
tating antibody were present. The results indicated that 
interaction of antigen with sensitized lymphocytes released 
a soluble substance, possibly a ’lymphokine’, which stimulated 
pyrogen-producing cells to release endogenous pyrogen (57). 
In Farr’s original results with BSA injections in 
sensitized animals, febrile reactivity to injected antigen 
seemed to be correlated with the presence of detectable 
antibody, in that precipitating antibody was present in all 
animals responding with fever, and no animal without detectable 
antibody responded to injection with fever. However, the 
exact role of specific antibody was unclear since there were 
animals which had the antibody present in their serum but 
in whom no febrile response developed to the injected 
antigen (55). 
Grey et a!L (6 7) provided the first evidence that fever 
due to injection non-bacterial protein antigens was 
primarily a phenomenon of "immediate,” or ’’humoral" 
hypersensitivity, by successfully inducing febrile reactivity 
in normal animals by passive transfer of specifically-immune 
serum to non-immune recipients. rive of seven recipients 
thus sensitized responded with fevers of 1°F or more when 
challenged with the BSA antigen. Passive transfer of non- 
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hyperimmune serum produced no such reactivity in "the recipient, 
and there was no response in normal, non-immune animals 
given only 3SA, thereby demonstrating the non-pyrogenicity of 
the BSA itself. However, spleen cell suspensions transferred 
to normal animals conferred no reactivity on the recipient 
when challenged. The results clearly implicated humoral, 
not cell-mediated, mechanisms. 
The work of Mott and Wolff (56) continued to mount 
evidence for the significance of antigen-antibody interactions 
when they showed a rough correlation between the degree of 
temperature change and the antibody titer of specifically- 
sensitized animals challenged with an injection of antigen, 
in this case human serum albumin (HSA), They also noted that 
of the six rabbits which had been sensitized (according to 
the protocol used for all the animals), but in whom challenge 
with HSA elicited no febrile response, all six had undetectable 
antibody. Furthermore, febrile reactivity to injected 
antigen in normal animals passively sensitized with speci¬ 
fically immune serum was comparable in incidence to that 
seen in immune animals. However, of seven normal animals 
passively "sensitized” with the "immune" serum containing 
no demonstrable antibody, only one responded Tn.th fever to 
challenge. 
Some clinical evidence to implicate the role of antigen- 
antibody interactions in the pathogenesis of fever was 
presented by Brittingham and Chaplin (68) who noted that 
febrile reactions to blood transfusions were associated with 
demonstrable antibodies against donor leukocytes in the 
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serum of those patients who had had both numerous (20 to 55) 
transfusions and repeated transfusion reactions. This group 
of patients responded with fever when injected with buffy- 
coat preparations of donor blood units, whereas the remaining 
red cell suspension of the donor blood resulted in no such 
response. This was compared to the responses of patients 
who had had fewer transfusions and no history of transfusion 
reaction. This group did not respond with fever to injection 
of either buffy coat or red cell suspension. Immuneiinter¬ 
actions were shown to be related to the fevers of certain clini¬ 
cal hemolytic disorders by Jandl and Tomlinson, who showed that 
hemolytic episodes due to immune hemolysis led to fever 
whereas hemolysis due to non-immune mechanisms had no such 
associated fever (69). Moreover, the degree of fever seemed 
to have no correlation to the degree of hemoglobinemia 
produced by different immune mechanisms, so fever correlated 
only with the presence of immune interactions, not with 
hemolvsis oer se. 
The work of Root and Wolff (70) was the first to directlv 
implicate antigen-antibody complexes as the specific pyrogenic 
mediator. They showed that antigen-antibody complexes ore- 
pared i_n vitro were regularly pyrogenic when injected into 
normal animals, a finding confirmed by Mickenberp et al_ (71). 
The pattern of febrile resoonse was used as an imoortant 
differentiating characteristic in separating out the action 
of endogenous ovrogen from the less direct effects o^ the 
antigen or the antipen-antibodv comolexes. Unlike the 
■ 
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response to endogenous pyrogen, which has been shown to be 
a prompt, monophasic fever with a latent period of approxi¬ 
mately 10 to 15 minutes (7), the fever curve after injection 
of antigen into sensitized animals was prolonged, with a 
longer latent period, a greater time interval to the oeak 
of the response, and a greater total duration (72). These 
same response characteristics were observed by Mott and Wolff 
after injection by HSA (56), by Grey in passive transfer 
experiments, and by both Root and Wolff (70) and Mickenberg 
et al_ (71) in normal animals injected with antigen-antibody 
complexes. 
The Dhenomenon of febrile tolerance proved to be a 
helpful tool to differentiate the pyrogenic effects of 
injected antigen from the effects of endogenous pyrogen 
to which tolerance has not been observed. Farr (72) noted 
originally that if sensitized rabbits which responded with 
fever to challenge with antigen were given repeated doses 
of the antigen, the febrile responses to the repeated injections 
became progressively smaller, with complete tolerance being 
achieved after 3 or 4 such injections. Several lines of 
evidence suggest that the phenomenon of tolerance to com¬ 
plexes differs from that of endotoxin tolerance, and may 
not be due simply to more rapid clearance from the circulation. 
Mott and Wolff (56) showed that the response to antigen in 
a sensitized animal was unaffected by a concomitant state 
of endotoxin tolerance in the animal, and that febrile toler¬ 
ance to antigen could not be abolished with reticuloendothelial 
. 
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blockade with Thorotrast, Furthermore, tolerance to antigen 
could not be passively transferred to sensitized animals, 
in clear distinction with endotoxin tolerance. Root and 
Wolff (70) also showed that the febrile response of normal 
animals to antigen-antibody complexes also was unaffected 
by a state of endotoxin tolerance. And Mickenberg et al (71) 
showed that tolerance to antigen-antibody complexes could 
persist when concomitant endotoxin tolerance in the same 
animal was reversed by reticuloendothelial system blockade 
with thorium dioxide. Thus, the pyrogenic effects of antigen 
in specifically-sensitized animals and of complexes in 
normal animals, can be readily differentiated from the direct 
effects of endogenous pyrogen and from the effects of con¬ 
taminating endotoxin. 
Root and Wolff, utilizing these phenomena, postulated 
a mechanism for the febrile reactivity to antigen injected 
into specifically sensitized animals. By challenging 
specifically sensitized rabbits with HSA and then collecting 
serum at 5 minutes after challenge and at 2 hours after 
challenge, thev identified two pyrogenic substances in this 
serum by injecting these collections into normal, unchallenged 
animals. The late-appearing pyrogen, present in the serum of 
febrile donors at 2 hours post-challenge, had characteristics 
identical to that of endogenous pyrogen, and the serum from 
afebrile doners 2 hours post-challenge had no pyrogenic 
acitvity. However, the serum from donors (all of whom were 
afebrile) at 5 minutes post-challenge gave pyrogenic response 
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characteristics unlike that of endogenous pyrogen and more 
like that observed in sensitized animals challenged directly 
with antigen. They demonstrated that at any time in the 
first hour after injection of antigen into a sensitized 
animal, approximately 50 oercent of the HSA was globulin 
bound, thereby suggesting that the HSA was present as 
circulating antigen-antibody complexes. It was the ability 
to produce febrile tolerance to injected antigen in a 
sensitized animal which enabled Root and Wolff to infer 
that their early appearing pyrogen was in +fact antigen- 
antibody complex, and that the mechanism by which it pro¬ 
duced fever was by release of endogenous pyrogen by the 
cells of the animal. By rendering complex tolerant- 
the rabbits which were given the early and late pooled 
serum collections, it was then observed that the late 
appearing pyrogen was able to mediate its effects in spite 
of complex tolerance. But the response of the early 
pyrogen in such complex tolerant animals was abolished. It 
was inferred that the early appearing pyrogen in the serum 
of sensitized animals challenged'with antigen, which had a 
fever curve indistinguishable from that of antigen- 
antibody complexes, and which had no effect in animals 
previously rendered Comdex tolerant, was, in fact, antipen- 
antibodv complex. And it was clear that the late appearing 
nyrogen, which had a fever response curve identical to that 
of endogenous pyrogen, and which was active desoite Comdex 
tolerance, was indeed endogenous pyrogen. So it was postu¬ 
lated that the mechanism wherebv protein .antigen such as HSA 
. 
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produced fever in actively or passively immune animals is by 
interaction with specific antibody to form antigen-antibody 
complexes which then interact with the cells of the host to 
stimulate the production and release of endogenous pyrogen. 
Grey et al (67) had postulated earlier that immune fever 
was probably mediated not directly by antigen or by 
complexes, but by a series of reactions in vivo since thev 
noted the long lag phase of the immune fever curve and noted as 
well that the time required for antigen-antibody inter¬ 
actions could not account for that time delay. 
In fever mediated bv antigen-antibody complexes, it 
is now apparent that only certain classes of antibody are 
probably involved (56), that the structural characteristics 
of the complex play a role (73), and that interactions with 
other immune mechanisms, namely the complement system, nav 
play a role (73). 
There is evidence that precipitating antibodies mediate 
the pyrogenic response to antigen-antibody Comdexes. Farr 
in his original observations (55) noted that specific kinds 
of antibodies might be involved, although he (incorrectly) 
concluded that precipitating antibody was not the active 
factor in serum, because of the observation that some 
animals with demonstrable precipitating antibodies to 3SA 
did not respond to the challenge of antigen. However, Foot 
and Wolff (70) showed with complexes prepared i_n vitro that 
soluble complexes in antigen excess, prepared by solubilizing, 
with antigen, the washed precipitates formed at equivalence, 
■ 
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were as active in producing fever as were the soluble 
complexes prepared simply by adding antigen directly to 
the immune serum. Furthermore, the supernatants from 
the equivalence precipitation reactions were uniformly ncn- 
pyrogenic when injected. This evidence seems to clearly 
implicate the precipitating antibodies as the active partici¬ 
pant in the febrile response to antigen-antibody Comdexes. 
That specific immunoglobulin classes may be responsible 
for febrile reactivity can be inferred from the results of 
Jandl and Tomlinson (69) in their work on the fever of 
immune hemolytic eoisodes. It was observed that hemolysis 
due to "incomplete” anti-D antibodies oroduced significantly 
more fever than did hemolysis due to A-anti A or 3-anti 3 
interactions. The "incomplete" anti-D antibodies are from 
the IgG (Immunoglobulin G) class whereas anti A and anti 3 
antibodies are IgM molecules (41). The significance of this 
class difference in relation to Jandl and Tomlinson’s 
findings is significant in light of the evidence gathered 
by Mott and Wolff (56) that passive transfer of febrile 
reactivity to injected HFA was successful only with fractions 
of serum which were shown by immunoelectroohoresis to con¬ 
tain predominantly 79 globulin. That fraction which was 
rich in 19S macroglobulin produced no significant febrile 
reactivity in the oassively ’sensitized' host. Thus, it 
seems that soecific characteristics of different immuno¬ 
globulin classes may have importance in determining the role 
of any immunoglobulin in the pathogenesis of immune fever. 
. 
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The macromolecular composition of immune complexes may 
play a significant role in producing fever. It is clear 
that in any given reaction mixture of antigen and antibody, 
whether in vitro (74) or in vivo (75), there is a hetero¬ 
logous mixture of different molecular species covering a broad 
range of molecular antibody to antigen ratios, including 
both free antibody and free antigen. And since these 
different molecular species seem to be handled by the host 
in different ways (75), and since they have different in 
vitro biological as well as physico-chemical characteristics 
(76), it is not surprising then that febrile reactivity to 
"antigen-antibody complexes" may represent the effects of 
one (or more) particular range or type of molecular species, 
It was well documented by Arend and Mannik (76) that 
complexes of different macromolecular characteristics 
differ in their clearance from the circulation. They demon¬ 
strated as well that a given reaction mixture of antigen 
with antibody contains a bread range of macromolecular 
species, of varying antibody to antigen molecular ratios. 
By subjecting complexes of HSA-anti HSA orepared in 5 times 
antigen excess to a density gradient centrifugation they 
observed a variety of resultant peaks: a 6.6S peak repre¬ 
senting unbound antibody and comprising approximately 20 
percent of the total; and a broad spectrum of larger complexes 
from 14S to 22S which comprised approximately 46 percent of 
the total. Then by sequential timed sampling of the serum 
of a rabbit after injection of soluble complexes prepared 
' 
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at five and at twenty tines antigen excess, and ultracentri¬ 
fugation of these sanples, it was shown that there was a 
three phase exponential disappearance curve. There was a 
rapid initial exponential component represented by uptake 
of the large (greater than 11S) complexes. Other work 
showed that 99 percent of this uptake occurred in the liver 
(75), There was a second exponential phase representing 
rapid equilibration of the 11S complexes, followed by a 
third prolonged exponential phase corresponding to slow 
catabolism of the IIS and 6.6S components. Furthermore, 
the large (>11S) complexes were most active in their in 
vitro comdement fixing activity, since approximately ten 
times as many of the 11S complexes were required to fix an 
equivalent amount of complement. However, comolement 
depletion of animals prior to injection of complexes had no 
effect on the rapid uptake of the large ( IIS) Comdexes. 
So it is clear that the in vitro activities of different 
species of complexes may not necessarily be of significance 
in determining their in vivo activities as it relates to 
clearance. And the authors concluded that the characteris¬ 
tics of the complexes which permit raoid clearance from the 
circulation parallel those which relate to comolement fixa¬ 
tion, but that the two characteristics are not necessarilv 
functionally related i_n vivo. 
Documentation that macromolecular composition of com¬ 
plexes may play a role in fever pathogenesis came when Root 
and Wolff (70) first produced fever in rabbits using HSA- 
. 
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anti-HSA complexes prepared rn vitro. They observed that com¬ 
plexes prepared at 10 times antipen excess (i.e. by adding, to 
serum 10 times the amount of antigen required for equivalence) 
produced significant fevers consistently/. Complexes pre- 
Dared at 21 times antigen excess or at 3 times antibody excess 
produced lower and more variable responses. Mickenberg (73), 
however, showed that the structural characteristics of com¬ 
plexes may determine the degree of the fever response 
indirectly, through variable ability to fix complement. 
They showed that rabbits could be made febrile either by 
% 
injection of PISA into an immunized animal or by injection 
of 10 times antigen excess complexes into a normal animal. 
However, treatment of these animals with cobra venom factor 
(resulting in complement depletion) orior to injection would 
abolish the responses of normal animals given the soluble 
complexes, whereas sensitized animals given antigen retained 
febrile reactivity. Since it was suspected that injection 
of antigen into a sensitized animal resulted in formation 
of large complexes like those formed at near equivalence or 
in antibody excess (75), complexes were preoared in 3 times 
antibodv excess, and when injected into unsensitized animals, 
were pyrogenic even in cobra venom treated animals. further¬ 
more, animals could be made tolerant to 10 times antigen 
excess complexes by repeated injections of the complexes. 
(This treatment also produced partial comolement depletion). 
However, such "complex tolerant" animals would still resoond 
with fever when injected with the antibodv excess complexes. 
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So it was apparent that a role for complement in the 
febrile response to soluble conolexes prepared in 10 times 
antigen excess was possible. Also, complement depletion 
seemed to affect other host responses to injection of Com¬ 
dexes: there was a decrease in the thrombocytopenia, a 
decrease in the duration of the leukopenia, and a marked 
reduction in the complement consumption observed as part 
of the response. Complement was further implicated by 
absence of an explanation of complex tolerance on the basis 
of more raoid clearance from the circulation or on the 
basis of a derangement of the effects of leukocyte endogen¬ 
ous pyrogen on the thermoregulatory center. That is, the 
only demonstrable change in complex tolerant animals was a 
(partial) dedetion of complement. On the other hand, it 
was not clear that complement played any role in the 
response to the antibody excess complexes, since complement 
depletion by previous treatment with cobra venom factor 
did not alter the response, and since the response was not 
altered even in those animals which were tolerant to the 
soluble 20 times antigen excess complexes. This set of 
observations was especially interesting in light of the 
fact that the antibody excess Comdexes fixed comdement 
in vitro much more rapidly than did the soluble antigen 
excess complexes and there was no significant difference in 
their in v: vo comdement consumotion. However, the difference 
in the in vivo consumotion mav well be related to markedly 
more raoid clearance of the larger complexes, thereby de- 

32 
creasing the total exposure time to serum complement compon¬ 
ents . 
So it seems clear that different ill vivo and in vitro 
biological as well as phvsiochemical properties may play a 
complexly inter-related role in the mechanism or mechanisms 
of immune fever. And it seems obvious that some of these 
complexities might be sorted out by determining how the 
complexes interact with the cells of the host when some of 
these parameters such as duration of presence in the circu¬ 
lation, complement requirements, and macromolecular compo- 
% 
sition of the complexes could be controlled; that is, a 
studv of the narameters governing the interaction of com¬ 
plexes with host cells in vitro would seem helpful. How¬ 
ever, such studies have not been forthcoming and numerous 
attempts to stimulate cells in vitro with antigen-antibody 
complexes have been unsuccessful, using blood cells, 
Kunffer cells, hepatocytes, and mononuclear cells from 
spleen preparations (31), However, it seemed reasonable to 
attempt to stimulate monocytes in tissue culture, as the 
monocyte reoresents the probable cellular orecursor of many 
tissue macrophages (34), and this preparation had been shown 
to be active with other stimuli such as heat-killed staphy¬ 
lococcus albus and endotoxin (.Bodel, unpublished observa¬ 
tions). Additionallv, the preparation is relatively sure 
in that one can eliminate most of the polymorphonuclear 
leukocytes and most o^ the small lymphocytes (the chief 
contaminating cell type). 

33 
MATERIALS AND METHODS 
Care of Materials and Anirials 
All glassware and instruments were rendered pyrogen 
free, after washing, by being heated in a dry oven at 170°C 
for at least 2 hours. Solutions and reagents were auto¬ 
claved at 120°C and 20 pounds pressure for at least 30 
minutes. 
New Zealand albino female rabbits, 6 kg in weight, 
were used as test animals. Temperatures were continuously 
recorded by a rectal thermistor probe connected to a con¬ 
tinuous graph readout. The ambient temperature of the 
recording room was maintained at 68 to 72°F. Animals 
were restrained in stalls during temperature recording, 
and had been trained by at least two 3-hour periods in 
such stalls prior to assay injections. 
Method of Injection and Recording of Temperatures 
The rabbits' temperatures were allowed to equilibrate 
such that a steady baseline temperature recording of at 
least one hour's duration was obtained. Each animal was 
given an initial injection of normal saline prior to assay 
injections. All were given into a marginal ear vein. Since 
animals may be somewhat refractory to the effects of endo¬ 
genous pyrogen during the hours following one profound 
febrile episode (77), injections into animals directly 
after high or prolonged fever was avoided. After a moderate 
febrile response, when the temperature had returned to its 
baseline value, at least one hour elapsed before the next 
- 
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injection was given. Only those responses which were of 
rapid onset, monophasic type were considered as true endo¬ 
genous ovrogen mediated responses (7), Maximum temperature 
change from baseline was used as the measure of febrile 
response. Occasionally, high fevers would be preceded by 
a slight, brief drop in temperature; in these instances, 
the maximum temperature rise was measured from the original 
baseline. In almost all experiments, pyrogenic testing 
of control and experimental samples was performed in the 
same group of rabbits, so that effects of variable 
responsiveness of individual rabbits on experimental results 
were minimized. Each rabbit received only 6 to 7 consecu¬ 
tive days of injections of human material, to prevent the 
complication of hypersensitivity fever (55). 
Immunization of Rabbits and Collection of Hyperimmune Serum 
Commercially prepared Bovine Gamma Globulin (BGG) 
(Armour Pharmaceutical Co,, Chicago, IL) was dissolved in 
0.1 Molar phosphate buffer, pH 7.0 to a concentration of 
5 mg per ml. Eight ml of this solution was mixed with an 
eaual volume of complete Freund’s adjuvant, and 0.5 ml 
portions were injected into each footpad of 4 New7 Zealand 
albino rabbits. Booster injections of 1 mg of BGG were 
given intravenously four weeks later. Seven to ten days 
later, the animals were sedated with sodium barbital and 
bled by cardiac puncture. Some animals received another 
1 mg of BGG intravenously 2 weeks after the first intra¬ 
venous injection, and were bled subsequently. Samples of 
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all sera were cultured to confirm the absence of contamina¬ 
tion, and were tested for specific antibody activity against 
BGG by Ouchterlony precipitation techniques. All sera 
were then pooled, divided into 5 ml aliquots, and frozen at 
-20°C, For the purposes of quantitative precipitation and 
formation of complexes for cell stimulation, 1:4 and 1:2 
dilutions were made in 0.1 Molar phosphate buffer, pH 7.4 
Iodination of BGG 
A solution of BGG was labeled with a radioactive tracer 
for the purpose of determining the equivalence point of the 
pooled sera by quantitative precipitation technique. 
Conjugation with protein with 1^25 was accomplished accord¬ 
ing to the methods of Greenwood et al (78). To 10 micro¬ 
liters of a 5 mg/ml solution of BGG was added 3 mCi of 1^25 
neutralized in 0.1 Normal HC1, and 20 microliters of 
Chloramine T (1.7 mg/ml in water) was added. This mixture 
was allowed to stand for 60 seconds and then the reaction 
was stopped by addition of 50 microliters of Sodium meta¬ 
bisulfite. This reaction mixture was then filtered through 
a Sephadex G-100 column equilibrate with 0.1 M phosphate 
buffer and successive 1 ml samples were collected. Aliquots 
of each tube were diluted and counted on a Nuclear Chicago 
scintillation counter, The first peak of radioactivity was 
saved, representing labeled protein rather than conjugated 
1125. 
Quantitative Precipitation of BGG with Rabbit Antiserum 
In order to determine the zone of equivalence for the 
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pooled sera, a quantitative precipitation was carried out. 
An initial precipitation was first performed by adding 1.0 
ml of 1:4 dilution of rabbit antiserum to varying amounts of 
a 1.0 mg/ml solution of BGG, These reaction mixtures were 
incubated at 37°C for approximately 10 minutes and then 
centrifuged at room temperature at 500 g for 20 minutes in 
an IEC Model PR-2 centrifuge. The supernates were decanted, 
and the precipitates washed with 0.1 Molar phosphate buffer, 
pH 7.4, followed by recentrifugation for a total of three 
such washings. Then the precipitates were solubilized in 
a 
0.5 ml of a 0.5 Normal solution of acetic acid, and made 
up to 20 ml by addition of water. Total protein concen¬ 
tration of these solutions were estimated by determination 
of O.D, at 280 millimicrons using a Coleman Model III 
spectrophotometer. These initial results Indicated an 
approximate range of antigen concentration for the zone of 
equivalence to be around 0,6 mg BGG Der 1 ml of 1:4 dilution 
of the rabbit antiserum. 
A further precipitation test was then set up using BGG 
conjugated with 1-^5 as a tracer. To variable amounts of a 
1 mg/ml solution of BGG (.4 ml to .8 ml) was added 20 micro¬ 
liters of the solution of radioiodinated BGG. This mixture 
was well agitated on a Vortex .mixer, and 1.0 ml of a 1:4 
dilution of the pooled rabbit antiserum was added to each 
tube. These were quickly mixed on the Vortex mixer, 
incubated at 37°C for 30 minutes and then centrifuged at 500 g 
for 20 minutes. Supernatants were drawn off with a Dasteur 
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pipette and saved. Each pellet of precipitate was then 
gently resuspended in 5 ml of 0.1 M phosphate buffer, pH 7.4, 
and centrifugation repeated. This supernatant was drawn off 
with a Pasteur oipette and added to the original supernatant. 
This washing orocedure was repeated twice more. Finally the 
washed pellet of precipitated complexes was solubilized in 
0.5 ml of a 0.5 Normal acetic acid solution and diluted to 
a total of 20 ml with water; supernatants were also made 
up to a final volume of 20 ml. 
A 1 ml aliquot of both supernatant and resolubilized 
precipitate was then counted for 1 minute in a Nuclear Chicago 
scintillation counter. The O.D. of the resolubilized pre¬ 
cipitates was then determined in a Coleman III spectro¬ 
photometer at 280 millimicrons to determine the total pro¬ 
tein content of the precipitate. The assumption was made 
that an O.D. reading of 1,5 units represented 1,0 mg/ml 
of protein. The amount of antibody precipitated in each 
tube was then calculated by subtracting the amount of antigen 
in the precioitate, determined by the radioactivity of the 
solubilized precipitate, from the total orotein content of 
the precipitate as determined by the O.D. reading. Assump¬ 
tions were made that the small amounts of radioiodinated 
3GG were negligible in relation to the amount of unlabeled 
antigen, and that labeled and unlabeled 3GG were well mixed 
and behaved identically; in the process of combining with 
the antibody. The equivalence point was chosen as that dose 
of antigen which precipitated the maximum amount of antibody. 
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Preparation of Complexes 
Soluble immune complexes in 10 times antigen excess were 
prepared in. vitro by adding 10 times the amount of antigen 
required for equivalence to a given amount of a 1:2 dilution 
of antiserum in a small test tube. The mixture was immediately 
agitated on a Vortex mixer and then incubated for approxi¬ 
mately 1/2 hour at 37°C, The mixtures were then centrifuged 
at room temperature, at 1000 g for 20 minutes. The super¬ 
natants were then decanted and added directly to tissue 
culture flasks containing the prepared monocytes. Complexes 
in 10 times antibody excess were similarly prepared by 
adding 10 times the amount of antibody required for equiva¬ 
lence to a given amount of antigen. Similarly prepared 
complexes were formed at 50 times antigen excess. The dose 
of complexes given to cells was varied by changing the 
concentration of BGG and the dilution of rabbit antiserum 
used in forming the precipitates. This method of varying 
the dose of complexes was chosen in order to maintain a 
constant volume of stimulus added to the tissue culture 
flasks, thereby eliminating the possible effects of differ¬ 
ential dilution of the culture medium by different stimuli. 
In cases where flasks were to receive no stimulus or a 
colume of stimulus material less than 1.0 ml in volume, the 
additional volume was added in the form of 0.1 Molar phos¬ 
phate buffer, pH 7,4. 
Precipitated complexes at equivalence and at 3 times 
antibody excess were prepared by adding the appropriate 
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amounts of antigen and antibody, incubating and centrifuging 
the mixture as above, and then decanting the supernate. 
The pellet was then gently resuspended in phosphate buffer 
(.1 Molar at pH 7.4) and recentrifuged at 1000 g for 10 
minutes. This washing was repeated twice, the final super¬ 
natant decanted, and the pellet was resuspended in an amount 
of phosphate buffer equal to the total initial reacting 
volume, with agitation on a Vortex mixer. Samples of this 
suspension of antigen-antibody complex particles were added 
directly to the tissue culture flasks of the monocytes. 
Isolation of Peripheral Monocytes 
Human peripheral blood monocytes and lymphocytes were 
isolated according to the method of Boyum (30). All 
procedures were performed with sterile, pyrogen free glass¬ 
ware and solutions, and utilizing sterile technique 
throughout. 
Twenty ml of 50% Hypaaue (sodium diatrizoate), 70.6 ml 
of a 9% aqueous solution of Ficoll (a large polysaccharide 
polymer, molecular weight approximately 400,000, from 
Pharmacia Fine Chemicals, Upsala, Sweden), and 9.4 ml of 
water were combined and 8 ml aliquots of this Hypaque-Ficoll 
solution were placed in 40 ml conical glass centrifuge 
tubes, 
Peripheral venous blood from healthy human volunteers 
was drawn directly from venipuncture into a large heparinized 
syringe (10 units/ml heparin). An additional 30 ml of 
unheparinized blood was drawn fro serum, Approximately 120 m 
\ 
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of blood was mixed in a large flask with approximately 
260 ml of saline and stirred slowly with a magnetic mixer while 
32 ml aliquots were gently layered over each 8 ml aliquot 
of the Hypaque-Ficoll solution. These tubes were then cen¬ 
trifuged at room temperature, at 400 g, for 40 minutes. 
After centrifugation red cells and PMNs were found at the 
bottom of the tubes. Approximately 1 to 2 cm above the 
upper border of this button was a white ring containing 
monocytes and lymphocytes. Above this ring was approximately 
30 ml of clear solution. This top layer of solution was 
removed by suctioning gently through a Pasteur pipette; 
the layer of monocytes and lymphocytes was then carefully 
removed with a 5 ml pipette with a pipette bulb attached. 
It proved helpful to scrape the sides of the glass with the 
tip of the pipette to remove attached cells. The rings 
from two such centrifuge tubes (approximately 10-12 cc) 
were combined in a new 40 cc conical centrifuge and diluted 
with 30 cc of a solution of Krebs-Ringer Phosphate buffer 
(KRP) containing 10 units/ml of heparin. After thorough 
mixing with a 10 ml pipette the tubes were centrifuged at 
room temperature, at 150 g, for 15 minutes, the wash super¬ 
natant discarded by suctioning, and the cells gently resus¬ 
pended in 0.5 to 1 ml of tissue culture medium (Minimal 
Eagles Medium with 50 units per ml of penicillin and 
streptomycin, and 200 millimolar L-nlutamine), All the 
cells were collected to make a pool or approximately. 8 ml 
of cells in tissue culture medium, A white blood cell 
. 
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count was performed on a Coulter cell counter Model 
(Coulter Electronics, Hialeah, FL), A small drop of the 
cell suspension was placed on a coverslip with a drop of 
albumin and smears were made for differential cell count. 
A total of 120 ml of peripheral blood usually yielded 15 
7 
to 20 X 10 cells of which 20 to 35% were monocytes, the 
remainder being lymphocytes. Granulocytes accounted for 
0 to 1% of the cells thus isolated. In some experiments, 
numbers of monocytes were confirmed by incubation of 0.2 ml 
of the cell suspension at 27°C for two hours with a drop 
of a suspension of heat killed staphylococci (3 X 10^ 
particles per ml). These cells were then suspended in 30 
ml of normal saline, centrifuged at room temperature, at 
400 g, for 15 minutes,- The supernate was decanted and the 
cell pellet suspended in a drop of albumin; coverslip smears 
made prepared, stained with Wright’s stain and examined 
under oil. Cells containing staphylococci were counted. 
Numbers of phagocytic cells compared well with estimates 
of monocyte count made by morphology. 
Incubation of Cells 
Tissue culture flasks were prepared containing approxi¬ 
mately 2 X 10^ cells (approximately 4 to 6 X 10^ monocytes) 
in a total volume of 6 ml,MEM with 15% homologous serum. 
Flasks were then gassed with 5% CO2 -in air, blown through a 
sterile, cotton plugged Pasteur pipette, and incubated at 
37°C for 3 hours. At this time, when the monocytes were 
observed to have attached to the bottom of the flask, the 
- 
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medium and floating cells (i.e. lymphocytes) were removed. 
Four ml of fresh medium, with 20% serum, was then gently added 
to the flasks, followed by 1 ml of experimental or control 
solutions. The final concentration of serum in the flask 
remained 15%. The flasks were then again gassed with 5% 
CO2 in air and incubated overnight (16 to 18 hours) in a 
5% CO^ incubator. After examination of the cells under a 
20X tissue culture microscope, the supernatants from the 
flasks were then transferred to centrifuge tubes, centri¬ 
fuged at 1000 or 2000 g. The higher speed was used for 
supernatants containing staphylococcal particles. The 
supernatants were then drawn up into svringes; two to 
three drops of each supernatant was added to tubes of 
thioglycolate broth and cultures incubated for at least 
3 davs to assure sterility. Data from injection of anv 
material which proved to be contaminated was excluded from 
the final results. 
In each experiment in which cells were obtained from 
a single donor, supernatants from all experimental flasks, 
usually six to nine, were tested for pyrogen in the same 
rabbits. Usually supernatant from a single flask provided 
two test injections which were given to two different 
animals. 
Analysis of Data 
In order to convert results of pyrogen assays to numbers 
with linear scale parameters, maximum temperature changes 
( & T max) were converted to units of pvrogen dose. The 
' 
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rationale and techniques of this procedure is as follows. 
When increasing doses of a preparation of human monocyte 
pyrogen were injected into a group of rabbits, a laganthmic 
function was observed. (Fig. 1) In the range of 0.3°C to 
0,9°C, A T max increases almost proportionally with dose, 
but a plateau is reached after which only small increases 
in & T max can be observed in response to relatively large 
increases in the amount of pyrogen injected. Similar 
response characteristics have been observed previously for 
human and rabbit granulocyte pyrogen (77, Bodel, unpublished 
observations). When the monocyte pyrogen response curve is 
plotted as a function of the logarithm of the dose of pyrogen 
administered, and the results analyzed by statistical tests 
for trend (79), a linear function best describes the 
curve. The best line describing the curve was determined 
by the method of least squares. When experimental data was 
analyzed, individual AT max values were converted to pyrogen 
dose units bv use of this curve, A single pyrogen dose unit 
was defined as the amount of pyrogen required to effect a 
A T max of 0.3°C, a minimal positive febrile response. The 
range of pyrogen units extended from 1.0 to approximately 
8.0 units. The scale of pyrogen doses was set to comply 
with this definition of a minimal febrile response, and all 
^ T max values were then converted to some constant 
multiple of the minimal pyrogenic dose unit. Therefore 
any response of /A T max equal to 0,3 C or greater corresponds 
to a pyrogen dose of 1.0 or greater, and is interpreted to 
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be a significant amount of pyrogen. Any A T max of less 
than 0.3°C corresponds to a pyrogen dose of less than 1,0 
and probably represents an insignificant amount of pyrogen. 
Any response which was not included within the range of the 
dose response curve was excluded as being uninterpretable. 
In the figures below, the data is presented as the statis¬ 
tical mean of at least 14 individual values, reported with 
confidence limits determined by the two-tailed t test (30), 
The number of actual observations made is also included. 
RESULTS 
Preparation of 1^25 Iodinated BGG 
In preparation for a quantitative precipitation test 
iodination of BGG with 1^25 was performed. After column 
chromatography of the reaction mixture in a Sephadex G-100 
column, two peaks of radioactivity were obtained, as shown 
in Fig. 2. As shown by others, the first peak includes 
the iodinated protein, and the broader second peak repre¬ 
sents unconiugated radioactive iodine (78), 
Determination of the Equivalence Point 
A series of quantitative precipitations were performed 
in order to determine the relative amounts of pooled antiserum 
and BGG required for equivalence, A preliminary precipitation 
using only non-iodinated BGG showed that maximum precipitation 
occurred when 1 ml of a 1:4 dilution of the pooled antiserum 
was reacted with approximately .6 mg of BGG (0.6 ml of a 1 
mg/ml solution). In order to further define the range of 
equivalence, precipitations were done using BGG to which 20 
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FIGURE 2. 
E1^ IODINATION OF BOVINE GAMMA GLOBULIN. 
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of I125 iodinated BGG had been added. The relative amounts 
of antigen and antibody in the supernatant and in the pre¬ 
cipitate were determined as described in Methods. Equivalence 
was defined as the point at which the maximum amount of 
antibody was precipitated. In Fig. 3, the milligrams of 
antibody precipitated is plotted against the amounts of 
antigen added to each reaction mixture, Maximum antibody 
was precipitated when 0,55 mg of BGG was reacted with 1,0 
ml of a 1:4 dilution of the rabbit antiserum. This deter¬ 
mination was then used to calculate amounts of antigen and 
antibody needed to form complexes of varying ratios in 
antigen or antibody excess. 
Additional quantitative precipitations were done with 
reaction mixtures containing 10 times antigen excess and 10 
times antibody excess to examine the total amount and compo¬ 
sition of protein in the soluble complexes present in the 
supernates of such mixtures. This was done to determine 
whether marked differences in total dose of soluble complexes 
would result from the two reaction mixtures. It was deter- 
minted that, in a 10 times antibody excess mixture, approxi¬ 
mately 64% of the antigen remained in the supernatant: and 
in a 10 times antigen excess mixture, approximately 71% of 
the antibody remained in the supernatant. These findings 
indicated that supernatants of these reaction mixtures con¬ 
tained roughlv similar amounts of protein, although it is 
likely that the exact molecular species present would differ 
markedly (74), 
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Temperature Responses of Rabbits to Human Monocyte Pyrogen 
Monocytes were incubated in tissue culture flasks over¬ 
night with heat killed staphylococci, and the supernatant 
was injected into rabbits. A typical temperature recording 
is shown in Fig, 4. The characteristics of this febrile 
response resembles those previously reported for leukocyte 
endogenous pyrogen, both human and rabbit (1, 25). There 
was a latent period after injection of approximately 15 
minutes, followed by a monophasic rise in temperature peaking 
within or at one hour and returning to the baseline within 
1 to 2 hours. Rabbits with higher peak temperature responses 
usually required more time to return to their normal base¬ 
line. No differences in the shape of the curve were 
apparent when other kinds of stimuli were used to initiate 
pyrogen production by these cells. 
Pyrogen Production bv Monocytes Incubated with Soluble Com¬ 
plexes in Antigen Excess 
Monocytes were incubated in the presence of soluble 
antigen-antibody complexes formed in 10 times antigen excess. 
Control flasks included one with monocytes incubated in 
medium without antigen or antibody, one with monocytes 
and antiserum, and one with monocytes and antigen. In 
addition, a flask containing heat killed staphylococci was 
included to provide a positive control. The results of 
one such experiment are shown in Fig. 5. Each curve repre¬ 
sents the average temperature response to 2 or more test 
animals. Whereas control injections produced little or no 
fever, injection of supernatants from cells plus soluble 
. 
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complexes produced clear, reliable febrile responses. 
A summary of the data from 14 experiments of this kind 
is presented in Fig. 6. As shown in bar A, monocytes incu¬ 
bated without any added material produced insignificant amounts 
of pyrogen. Since a minimal positive pyrogenic response 
(AT max of 0.3°C) corresponds to a Dyrogen dose unit of 
1,0, the mean value for monocytes alone, is 0.6 - .12 units 
(p <. 0,001, n=24). That is, there is less than a 0,1% 
chance that monocytes alone produce significant amounts of 
endogenous pyrogen. 
Similarly as shown in bar B, monocytes do not produce 
significant amounts of pyrogen after addition of either 3GG 
or antiserum, in doses equal to or greater than those 
present in the preparations with soluble complexes. The 
mean value for these pyrogen doses (taken together to 
provide a statistically adequate number of trials), is 
0.72 ~ .06 units (p < 0.001, n=14). That is, there is less 
than a 0.1% chance that cells in the oresence of BGG or 
rabbit antiserum produce significant amounts of pyrogen. 
3y contrast as shown in bar D, addition of soluble 
complexes to monocytes stimulates the production of endo¬ 
genous oyrogen. The value of the mean pyrogenic dose for 
these supernatants is 2.3 i ,88 units (p <. .001, n=36), 
significantly greater than 1,0, Heat killed staohylococci 
were also potent stimuli of oyrogen production by monocytes 
(see bar E), The mean pyrogenic dose was 3.3 i .79 units 
(p -c 0.05, n=17). This corresponds to a mean temperature 


FIGURE 6 
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response somewhere in the range of 0,67 to 0,84°C, 
In order to demonstrate that the pyrogen present in 
supernatants from tissue culture flasks containing cells and 
complexes was, in fact, endogenous pyrogen, and not 
antigen-antibody complexes themselves, the following 
experiment was performed. Tissue culture flasks without 
cells were prepared containing tissue culture medium and 
soluble complexes. These flasks were incubated and treated 
identically to other flasks which contained cells. Injections 
of the centrifuged supernatants were uniformly non-pyrogenic, 
the mean pyrogen dose being 0,4 - .14 units (p < 0.001, 
n=15) (see Fig. 6, bar C). Thus the pyrogen present in 
flask supernates after incubation of complexes with 
monocytes was most likely due to a substance produced by 
the cells in tissue culture rather than the complexes alone. 
Pyrogen Production bv Monocvtes Incubated with Varying 
boses of Soluble Anti pen-Antlbody Complexes m To Times 
Anti pen Excess 
To test whether the amount of pyrogen produced by the 
monocytes was directly related to the number of complexes 
added, equivalent numbers of cells in culture were stimulated 
with different amounts of soluble complexes prepared in 10 
times antigen excess. Equal volumes were maintained by 
diluting the solutions of antigen and antibody before 
preparing the complexes. The lower dose was given by adding 
1 ml of soluble complexes prepared by mixing a 1 mg/ml 
solution of 3GG with a 1:4 dilution, in buffer, of the 
rabbit antiserum, or by adding 0.5 ml of :uffer plus 0.5 ml 
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of the high dose solution. The high dose solution was 
given by adding 1 ml of soluble complexes prepared by mixing 
a 2 mg/ml solution of BGG with a 1:2 dilution of the rabbit 
serum. As seen in Fig, 7, bars BSC, there is a positive 
correlation between the concentration of complexes added to 
the monocytes and the amount of pyrogen produced. The low 
dose of complexes stimulated production of 1.5 - .18 units 
of pyrogen (p 0.01, n=23), while the higher dose of com¬ 
plexes stimulated production of 2,3 - ,67 units (p <0,01, 
n=36). There is less than a 1% chance that the two doses 
stimulate production of equivalent amounts of pyrogen. 
Comparison of Production of Monocyte Pvro?en in Fesnonse 
to Qualitatively Different Antigen-Antibody Complexes' 
Since complexes of varying size and differing antibody 
to antigen ratio are known to have different in vivo and in 
vitro biological activities, the effects of soluble com¬ 
plexes prepared in 10 times antibody excess and in 50 times 
antigen excess were compared to those of the 10 times 
antigen excess complexes. The results are presented in 
Fig. 8, Soluble complexes in 10. times antibody excess 
stimulated production of 1.9 - .90 pyrogen units (p < 0.01, 
n=18). This finding indicates that soluble complexes in 
antibody excess are also capable of stimulating cells. 
Although this figure is lower than the one for 10 times 
antigen excess, direct comparison of the 10 times antibody 
excess complexes with the 10 times antigen excess complexes 
seems not justified, since differences in pyrogen production 
follow alteration in dose of complexes (see above), and it 
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FIGURE 8 
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was not possible to accurately quantitate numbers of complexes 
in each system. However, it was noted that a mixture of 
10 times antibody excess complexes produced a significantly 
larger pellet of precipitate than did the 10 times antigen 
excess complexes. Thus, the amount of complexes present in 
soluble form was probably less than that in the 10 times 
antigen excess mixture. 
Complexes prepared in 50 times antigen excess were also 
added to the monocytes, and pyrogenicity of the supernatants 
determined. In this case, the amount of complex present 
in the soluble form was clearly greater than that found in 
the 10 times antigen excess mixture. However, stimulation 
of pyrogen production by the soluble complexes prepared at 
50 times antigen excess was not clearly demonstrated; the 
mean pyrogen dose was 0.8 - .17 units (p ^.0.4, n-14), 
Fig. 8, bar C. This indicates that there is an approxi¬ 
mately 80% probability that the mean amount of pyrogen 
produced was not a significant amount. The response was 
clearly lower than the response to 10 times antigen excess 
complexes, even though there were at least as many soluble 
complexes present at 50 times antigen excess, since there was 
virtuallv no precipitate in this mixture. 
Response of Monocytes to Anti gen-Ant ibodv Comp lex ne c 
tates~ 
Since monocvtes produce pyrogen after simple phagocy¬ 
tosis of particles such as heat killed ssaphvlococci , it 
was necessary to be sure that the responses observed with 
soluble complexes were not due to phagocytosis of particles 
' 
» 
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of precipitated complexes which might remain after centri¬ 
fugation or which might form inadvertently in the flasks. 
In addition, the effect of precipitates of antigen-antibody 
complexes on monocyte pyrogen production was of interest. 
Therefore, precipitates formed at equivalence, at 3 times 
antibody excess, and at 10 times antibody excess were 
prepared, washed 3 times to remove any remaining soluble 
complexes, resuspended in phosphate buffer, and added to 
the standard cultures of monocytes. The results of these 
supernatant injections are shown in Fig. 8, bar D. Immune 
precipitates uniformly failed to induce pyrogen production. 
The mean pyrogen dose was 0.6 - ,08 units (p < 0,001, n=19). 
In order to ensure that the precipitates had not injured 
the cells, preventing them from producing pyrogen, an 
experiment was included in which heat killed staphylococci 
with and without precipitates were added to some cells. 
In this case, a large amount of pyrogen was produced, both 
in the presence and absence of precipitates, in response 
to the staphylococci. Thus there was no evidence that the 
precipitates inhibited pyrogen production. 
Microscopic Observations of Monocytes in Tissue Culture 
Tissue culture flasks were usually examined,after 
incubation for approximately 18 hours, under a tissue 
culture microscope at 20X magnification. The observations 
may be summarized as follows. Monocytes incubated in medium 
alone appeared as cells which were fixed to the flask 
surface, with minimal numbers of cells floating free in the 
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medium; cells were separate and unclumped, round or oval, 
and displayed a minimal granular appearance to the cyto¬ 
plasm with occasional ameboid shapes with cytoplasmic extensions. 
Cells that had been stimulated by either staphylococci or 
antigen-antibody complexes in 10 times antigen or antibody 
excess appeared somei'Niat larger, most still fixed to the 
surface, but often with significant numbers of floating, 
single cells or cell clumps. Cells fixed were often 
clumped together and were usually round. A more heavily 
granular appearing cytoplasm was evident in most cells, 
fixed and floating. In general, these changes of clumping 
and granularity were produced to a greater degree by 
stimuli in the following order: staphylococci > high dose 
soluble, 10 times antigen excess complexes > soluble 10 
times antibody excess complexes > low dose soluble 10 times 
antigen excess complexes. In general, soluble, 50 times 
antigen excess complexes produced only minimal changes. 
Negligible changes were observed with BCG alone or with 
antiserum alone. However, resuspended precioitates were 
found to produce marked changes as described above, with 
large masses of floating cell clumps as well as some fixed 
cell clumps. Because more accurate microscopy was not per¬ 
formed the exact relationship of these changes to specific 
alterations in cell morphology is not known, 
CONCLUSIONS AND DISCUSSION 
The results of these experiments indicate that immune 
complexes can interact with pyrogen producing cells to 
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stimulate the production of endogenous pyrogen. While Root 
and Wolff (73) have shown previously that injection of anti¬ 
gen into a sensitized animal was associated with the appearance 
of endogenous pyrogen in the circulation, the in_ vivo 
pathways, presumably involving interactions of complexes 
with some cells, were unknown, Atkins et al attempted to 
stimulate blood cells, predominantly polymorphonuclear 
leukocytes, with complexes of rabbit antiserum and BGG-DNP, 
and failed to generate any detectable pyrogen (57). However, 
only complexes in 30 to 1 and 80 to 1 antigen excess were 
used as stimuli, and these complexes have been shown in the 
present experiments to be relatively ineffective in 
stimulating monocyte pyrogen production. In another in 
vitro model, Chusid and Atkins (60) incubated leukocytes 
from rabbits hypersensitive to penicillin-protein conjugates 
with antigen and antiserum and noted endogenous pyrogen 
production. However, since the blood preparation was 
undoubtedly a mixture of PMNs and monocytes, the specific 
pyrogen-producing cell in this system is not known. In the 
present experiments it is extremely unlikely that contamina¬ 
ting numbers of PMNs are responsible for the observed 
responses. Less than 1% PMNs were counted in the differ¬ 
ential smears of the cell preparations; therefore, no 
more than 2 X 10^ PMNs were present in any flask. Atkins- 
and Bodel (1) reported that any number of PMNs below 5 X 
g 
10 produced negligible amounts of pyrogen in response to 
tuberculin. Contaminating granulocytes, therefore, could 
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not account for the pyrogen production by incubated monocyte 
preparations. Lymphocytes are also probably not responsible 
for pyrogen production in these experiments, since cultures 
of the non-adherent cells from monocyte-lymphocyte prepara¬ 
tions with added complexes did not result in endogenous 
pyrogen production (Bodel, unpublished observations). In all 
other systems tested, lymphocytes have failed to produce 
pyrogen (31). Lymphocytes present in tissue culture flasks 
may play a role in the observed endogenous pyrogen produc¬ 
tion, Some lymphocytes were doubtless present, even after 
non-adherent cells were removed, since the monolayers were 
not washed in any way. And lymphocytes have well-described 
receptors for antigen-antibody complexes (45), and exert 
numerous effects on macrophages (83), It is possible, 
therefore, that the complexes may act on the lymphocytes, 
which in turn stimulate the monocytes to release pyrogen. 
The observed febrile responses to suoernatants from 
cultures of monocytes plus complexes were clearly due to 
pyrogen produced in the incubated cells. Complexes incu¬ 
bated without cells in tissue culture medium did not produce 
significant fevers when injected into test animals in 
amounts equal to or greater than those present in flasks 
containing both cells and complexes. Thus, the complexes 
themselves in those small concentrations were non-pyrogenic 
in rabbits. Further evidence for this conclusion that 
the comnlexes were not acting directly on the cells of 
the test animal is found in the shame of the fever curve 
- 
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which looks indistinguishable from a tyoical endogenous 
pyrogen mediated response. 
The results also demonstrated that, in the case of 
soluble complexes formed at 10 times antigen excess, the amount 
of pyrogen released by the cells was directly related to the 
concentration of complexes added to the cells. This could 
indicate that a single cell produces more pyrogen when it 
experiences more interactions with complexes. On the other 
hand, a minimum number of cell interactions with complexes 
may be required to stimulate any cell to respond with 
pyrogen production. When the number of complexes present 
in the medium is increased, more cells may achieve inter¬ 
actions with the minimum numbers of complexes. It is not 
known whether stimulation of cells to produce pyrogen is a 
simple ’off-on' phenomenon, with, in this case, increasing 
numbers of cells to the active state. One would suspect 
that if the complexes were evenly distributed throughout 
the culture medium in the flask, cells would be fairly 
uniformly exposed to equivalent numbers of complexes. 
However, if an irreversible attachment to the cell surface 
or interiorization of the complexes is a prerequisite to 
stimulation, then the metabolic state of individual cells 
may dictate which ones are activated more raoidly, consuming 
or fixing complexes which are then no longer available to 
other cells which have not as rapidly interacted with enough 
complexes for activation. Addition of more comolexes 
to the system would then allow a greater number of cells to 
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be activated. 
Some results surest that the cell preparations do not 
require continuous stimulation by the complexes for endogenous 
pyrogen production to continue. In a few experiments, the 
monocytes were stimulated with complexes, and after 18 hours 
of incubation, the supernatant fluid was removed from the 
flask and replaced with fresh tissue culture medium. Rein- 
cabation of these cells allowed continued production of 
significant amounts of pyrogen even in the absence of the 
complexes. This finding may reflect a fundamental irre¬ 
versibility to the activated state. Once activated, the 
cell may be essentially independent of the amount of 
stimulating substance present. It has been shown in .other 
systems that activation of PMNs completelv precedes any 
pyrogen oroduction (82). 
Comoarison of the data for cell preparations stimulated 
with 10 times antigen excess complexes and 50 times antigen 
excess comolexes suggests that qualitative differences in 
the structure of the complexes may play a role in determin¬ 
ing their potency as stimulators of pyrogen production. Arend 
and Mannik have shown that complexes formed in vivo (75) 
and i_n vitro (74) are not uniform in size or molecular 
antibodv-antigen ratio. Using human serum albumin (HSA) 
and rabbit antibodies to HSA, they showed that soluble 
complexes formed in a mixture of 5 times antigen excess 
contained free antibody (20% of total protein), comolexes 
of antibody to antigen of molar ratios of 2:1 (34%), and 
- 
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complexes of larger size comprised of more than 1 antigen 
and more than 2 antibodies (46%) (75). A mixture of 20- 
times antigen excess complexes contained only 32% large 
complexes and more (48%) of the small complexes. In 
greater antigen excess there are lesser amounts of large 
complexes and increased amounts of small complexes, and 
the same in orobably true in our system. 
It is clear from our data that the complexes prepared 
at 50 times antigen excess are essentially ineffective as 
stimuli of monocyte pyrogen production, while complexes 
formed at 10 times antigen excess, or 10 times antibody 
excess are effective. Larger complexes, therefore, may be 
the active macromolecular moiety in our system, although 
this is not proven. There mav be alternative explanations 
for our findings. Equal volumes of the various complex 
mixtures were added to our preparations, in order to 
eliminate effects of var^/ing the concentration of the cultur 
medium. Therefore equal volumes of comnlexes of varying 
antigen antibody proportions were compared. Therefore, 5 
fold less total antibody was present in the 50-times antigen 
excess preparation than in the 10 times antigen excess 
preparation (high dose). Since, as noted above, there is 
some dose relationship) for activation of the cells, the 
observed negative responses at 50 times antigen excess may 
be due to inadequate total dose of complexes, when measured 
by the antibody moiety, rather than qualitative differences 
in complex structure oer se. However, when complexes were 
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preoared at 20-times antigen excess (data not included in 
results because only 8 values were obtained), the average 
fever response was only 0,25°C, corresponding to a pyrogen 
dose of less than 1,0 units, These 20-times antigen excess 
complexes did contain amounts of antibody equal to that 
present in the low dose 10-times antigen excess complexes, 
which were shown to stimulate significant amounts of pyrogen 
production (see Fig, 7), So while the ineffectiveness of 
the 50 times antigen excess complexes may be a result of 
dose effects, it appears that qualitative aspects of the 
complexes also play a role. 
The 50 times antigen excess complexes may be poor 
stimuli as a result of the ratio of globulins present, since 
in this system the antigen is itself an immunoglobulin. 
Although commerciallv preoared BGC probably contains mostly 
denatured protein, some intact BGG is probably also present. 
If the mechanism bv which complexes stimulate monocytes 
is a specific interaction between the Fc region of antibody 
in complexes and a specific immunoglobulin receotor on the 
ceil surface, then free immunoglobulin may competitively 
inhibit the interaction, as is observed in other cell-complex 
interactions. Free BGG present in the antigen excess mix¬ 
ture, therefore, may exert an inhibitory effect on the 
complex-mediated stimulation of cells. Arend and Mannik (39) 
have shown that there is only partial soecies specificity 
for inhibition of cell-complex adherence, so the exact 
effects of free BGG, or even free rabbit antibody, on the 
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cell-complex interactions in this system are unknown. 
Similar mechanisms of competitive binding, and low dose 
of complexes may be playing a role in the resoonse observed 
with antibody excess complexes. While they clearly had a 
positive stimulating effect on cells, in the amounts given, 
the statistical mean of the pyrogen dose produced is lower 
than that observed with the same "dose” of 10 times antigen 
excess complexes (1.9 - .70 pyrogen units compared to 2.3 - 
.50 units for antigen excess), although there is some 
probability that the statistical means might be in the same 
range. Cells may have, in fact, received a lower dose of 
antibody excess complexes. When preparing complexes in 
vitro it was observed that the gross size of the precipitate 
pellet was much larger in the antibody excess tube as 
compared to the antigen excess precipitate which appeared 
minuscule. So the total dose of complexes present in a 
given volume of the antibody excess supernate may well have 
been considerably lower than that present in the antigen 
excess supernate. Additionally, if the complex-cell inter¬ 
action is inhibited by free antibody, then free rabbit 
antibodies present in antibody excess mixtures may have had 
an inhibitory action of the stimulating effect of the 
complexes which were present. Considered together, this 
might indicate that if an active fraction of complexes could 
be separated from the total complex mixture, complexes formed 
in antibodv excess might, in fact, be a more potent stimulus 
for pyrogen production than complexes formed at antigen 
excess. 
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That is, a range of larger complexes may be the active 
molecular species. By preparing complexes in antigen excess, 
one may be decreasing the total dose of the active molecular 
fraction by forming increased amounts of small complexes of 
antibody to antigen ratio of 2:1 or less. These small com¬ 
plexes may render the small amount of large complexes 
ineffective bv directly inhibiting the action of the larger 
complexes present, just as does the free BCG. Phillips- 
Quagliata (46) showed that complexes with monovalent antigens 
not only fail to attach to cells, but also markedly inhibit 
the attachment of complexes with polyvalent antigen. Thus, 
small complexes present in large amounts in far antigen 
excess may represent complexes of functionally monovalent 
antigen which are both non-stimulatory themselves, and 
inhibitory to the attachment of adequate numbers of the 
active, larger complexes. 
Precipitated complexes did not stimulate monocytes to 
produce pyrogen in this system, even though they contain 
relatively large complexes. At equivalence, the calculated 
antibody to antigen ratio for the precipitated complexes is 
approximately 3:1, antibody to antigen; in antibody excess, 
complexes of this size or larger are probably present. In a 
similar system, precipitated complexes are readily inter- 
iorized by macrophages, localized in ohagolysozomes, and 
subsequently degraded (33). It may be argued that perhaps 
the cells did not phagocytose the precipitates. It was not 
demonstrated that such phagocytosis in fact took place. How- 
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ever, the cells were clearly capable of phagocytosis of 
staph particles and capable of pyrogen production while m 
the presence of the precipitates, and mononuclear cells are 
known to phagocytize a wide variety of particulate substances 
including cellular debris, without a requirement for 
opsenizing antibodies. And the microscopic appearance of 
the cells in the presence of precipitates suggested wide¬ 
spread and extreme cell activation, the cells appearing 
grossly enlarged, granular and clumped into large aggre¬ 
gates. This corresponded in appearance to that observed 
in flasks in which phagocytosis of heat killed staphylo¬ 
coccal particles had occurred. So while not proven, it is 
suggested that the cells phagocytosed the complex precipitates, 
but were not stimulated to produce the pyrogen. 
Consequently, although phagocytosis in our system was 
not proven, it is likely that the production of pyrogen may 
not be simply a nonspecific concomitant of phagocytosis of 
particles. Phagocytic cells are known pyrogen-producing 
cells (1,25,29) and, in general, greater amounts of pyrogen 
are produced in response to larger amounts of phagocytic 
stimulus (1). There are numerous kinds of particles which 
are readily phagocytosed by such cells (34). However, many 
soluble substances are adequate stimuli also, such as 
etiocholanolone (20), tuberculin (1) and endotoxin (Bodex, 
unpublished observations). And since the stimulus for 
pyrogen production in the presence of immune complexes is 
presumably not phagocytosis per se, a more specific complex- 
Hr 
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cell interaction must be postulated to account for the 
observed stimulation by the complexes in solution. 
The most likely mechanism by which complexes stimulate 
the cells to pvrogen production may be through specific 
attachment to the immunoglobulin receptors on the cell 
surface. In the case of precipitates, such interactions 
may be infrequent. It is well known that the process of 
formation of antigen-antibody complex is a two step 
process: first attachment of the antibodies by the Fab 
region attaching site, to numerous exposed antigenic deter¬ 
minants on the antigen molecule. The process of precipi¬ 
tation per se is due to noncovalent intermolecular inter¬ 
actions between numerous such antibodies on one or more 
antigens in such a way-that water is excluded from the 
complex, and it forms an insoluble precipitate (84). So, 
in precipitate form,the specific region of the Fc fragment 
required for interaction with cells mav be bonded noncovalentlv 
to other antibodies and thus unavailable for attachment to 
the specific cell receotor altogether, and/or the combining 
site may have too much simple steric interference from 
neighboring molecules. This theory, then, would suggest that 
precipitates are probably phagocytized non-specificallv as 
particles, whereas soluble complexes interact first with 
numerous adjacent cell surface receptors, thereby stimulating 
activation of the cell processes, including pvrogen production. 
Precipitates mav have failed to initiate pvrogen produc¬ 
tion through alterations in the availability of complement. 
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Precipitated complexes, unlike soluble ones, were washed, 
removing other rabbit serum factors,and one might question 
whether absence of complement was the reason the precipitates 
seemed to elicit no pyrogen response. However, rabbit anti¬ 
body fixes human complement (85), and the tissue culture 
medium contained 15% fresh human serum, presumably an adequate 
source of complement. 
Studies of the factors required for activation of mono¬ 
cytes by soluble complexes were limited. Several experiments, 
however, showed clearly that heating both rabbit and human 
sera prevented all activation (3odel, unpublished observa¬ 
tions). This data suggests the importance of complement 
to the reaction. 
While much literature data on the interaction of complexes 
with cells, both in vivo and in_ vitro, has been presented 
on the role of complement in such reactions, the exact 
role complement plays in this system remains to be defined. 
Complement factors may stimulate pyrogen oroduction quite 
independently of the actual cell-complex interaction. This 
seems unlikely, since complement fixing precipitates should, 
then, activate the cells. On the other hand, cells may 
be activated bv a theoretical cell-comolex interaction 
quite independently of a concomitant complement consumotion 
reaction. It has been proposed that in vivo uotake of 
large complexes, which fix complement most readily, is a 
phenomenon quite separate from their observed in vitro 
complement fixing abilities (75), It has been also suggested 
. 
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by Mickenberg et al_ (73) that the pyrogen producing ability 
of large complexes formed in antibody excess is a complement- 
independent phenomenon, since cobra venom factor-treated 
rabbits retain febrile reactivity to such complexes, unlike 
smaller complexes which are formed in antigen excess. 
However, much data supports the view that complement does 
play a role in the pathogenesis of immune fever. For 
example, Mickenberg showed convincingly that complement 
depletion eliminated febrile responsiveness to antigen 
excess complexes (73). 
a 
One hypothesis which might explain the apparently 
conflicting results is that complement independent 
attachment of soluble complexes to cells in this system 
may indeed take place concomitantlv with a probably 
comolement dependent mechanism of pyrogen production. 
According to this theory, the phenomenon of stimulation of 
pyrogen production may be a separate one from that of 
attachment and subsequent interiorization by the cell. 
It is apparent from our data and from that of others 
(73), that there is a finite range of size (lattice size) 
of antigen-antibody complexes which activate mononuclear 
cells to produce pyrogen, or cause the release of enzymes 
polymorohonuclear leukocytes (00), However, Arend and 
Mannik have shown that clearance of antigen-antibody 
complexes of all sizes from the circulation of animals is 
virtuallv complete, 90 percent being removed by the liver 
(75). Clinical evidence suggests that the immunopatholog.ic 
. 
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activity of complexes is not primarily due to presence of 
complexes in the circulation, but rather to abnormal 
localization of complexes in sites from which they are not 
rapidly cleared, e.g, in the kidney (86), in the walls of 
blood vessels (87), in the cerebrospinal fluid space (88), 
This suggests that uptake of complexes from the circulation 
by cells of the reticuloendothelial system may not be the 
mechanism of pyrogen production. It may be that separate, 
probably complement dependent, interactions take place 
between cells and soluble complexes of large size (> 11S 
sedimentation coefficient) resulting in activation of 
mononuclear cells, with the production pyrogen as one 
result, 
When Mickenberg et al showed that antigen excess com¬ 
plexes of human serum albumin (HSA) and rabbit anti-HSA, lost 
their fever producing capability in decomplemented rabbits, 
while antibody excess complexes retained fever producing 
ability in such animals, they concluded that "large” com¬ 
plexes formed in antibody excess produced fever independently 
of comnlement, that the in vitro complement fixing ability 
of the large complexes only "paralelled” their fever producing 
activity. They concluded that "small” complexes in the 
antigen excess mixture were probably not representative of 
the complexes which form when antigen is injected into an 
immune animal, and could be disregarded as being responsible 
for any fever producing activity oroduced by injection of 
the antigen. However, Arend and Mannik have shown that 
large complexes are, in fact, present in mixtures of 10 
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(and greater) times antigen excess. Perhaps what happened 
in Mickenberg’s (73) experiments is that complexes of 
sufficient size, but at the small end of the range of 
active complexes oresent in the antigen excess mixture 
produced fever by a complement dependent mechanism. Re¬ 
peated injections of complexes produced increasing con¬ 
sumption of complement components to the point where the 
smaller, relatively inefficient complement fixing complexes 
could no longer activate enough complement sufficiently 
rapdily to produce activation of cells. Similar (partial) 
depletion of complement, by treatment with cobra venom 
factor, rendered the complexes again incapable of initia¬ 
ting activation of the host cells to make pyrogen. However, 
when large complexes, at the larger end of the range of 
active Comdexes, were injected, their more efficient 
comnlement fixing ability allowed them to initiate a 
(complement dependent) response even in the face of 
(partial) complement depletion. Indeed, further reduction 
in complement was observed when the antibody excess complexes 
were injected. That the large complexes consumed less 
comdement in vivo, in a normal animal, than did antigen 
excess complexes, can be accounted for on the basis of 
their much shorter life span in the circulation. Clearance 
of complexes by the RES may be what stopped their activity 
in stimulating cells to produce pyrogen, rather than what 
produced the pyrogen. 
Obviously, data is required to deters.' ".e exactly what 
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in vitro mechanisms are in fact operating to lead to cell 
stimulation. The theory presented herein accounts for 
observed phenomena in Mickenberg’s in vivo system, and is 
consistent with the observed data for complex-cell inter¬ 
actions as well as the present finding that phagocytosis 
of complexes per se does not result in pyrogen production. 
Coincidentallv it offers a possible theory of febrile 
complex tolerance, i.e. complement depletion, which can 
account for complement dependent cell activation to pyrogen 
production in the face of complement independent mechanisms 
observed in uptake of complexes by macroohages in vitro and 
clearance of complexes in vivo. 
Similar mechanisms of complement dependent cell activa¬ 
tion without phagocytosis have been proposed in other systems. 
Miller ejt al (89) have observed complement mediated release 
of complexes from lymphocyte surfaces, involving the properdin 
pathway of complement activation. The authors propose that 
antigen-antibody induced activation of the normal complement 
sequence leads to attachment of an antigen-antibody-complement 
complex to the cell surface. However, subsequent activation 
of the alternate oathway Droduces intermediates which then 
cause the release of the complexes, thereby mediating a 
possible transient association of antigen-antibody complexes 
with the cells, possiblv resulting in some form of cell 
activation without concomitant phagocvtosis. Certainly such 
a mechanism is an attractive one for interpretation of the 
complex induced cell activation leading to production of 
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pyrogen. 
Many aspects of immune fever, both experimental and 
clinical, remain unclear. What is the exact nature of the 
complex-cell interaction? Is pyrogen production a necessary 
concomitant of attachment and phagocytosis of complexes by 
cells of the RES, or can uptake and clearance of complexes 
occur without pyrogen production? What other cells are 
capable of being activated by complexes? Which cells are 
the active ones in various hypersensitivity disease states? 
Are other mechanisms of cell activation involved? Does 
complement play a role in attachment? interiorizat.ion? 
cell activation? What mechanisms operate in vivo to result 
in defective clearance of complexes and localization of 
complexes in sites where they mediate inflammation and 
injury? Exactly what kinds of complexes are active stimu¬ 
lators of cells? What antibody class and subclass 
specificity exists for fever production? What kinds of 
naturally occurring exogenous and endogenous antigens are 
responsible for observed clinical hypersensitivity states 
in which fever is a part of the symptom complex? 
Hopefully, further studies using our in vitro system 
mav help to answer some of these questions. When various 
molecular species present in a reaction mixture of complexes 
are separated, the effectiveness of large and small species 
can be directly evaluated. Further experiments with 
decomplemented serum need to be carried cut to determine the 
exact complement requirements of the pyrogen production 
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phenomenon. Use of different antigens may help elucidate 
mechanisms of fever production in clinical states 
associated with antigen-antibody complexes involving host 
antigens such as DMA, and glomerular basement membrane. 
And much remains to be done to determine the relations 
between the mechanisms of immune fever production and those 
involved in the pathogenesis of immune complex disease. 
SUMMARY 
Human peripheral blood monocytes were stimulated rn vitro 
by soluble antigen-ar.tibody complexes to produce endogenous 
pyrogen, A dose-deoendent relationship was observed between 
pyrogen production and the amount of immune comolexes present 
in the medium surrounding the cells. Qualitative differences 
in the size of comolexes were inferred to play a role in 
determining the potency of complexes as cell stimulators. 
Precipitated antigen-antibody complexes were inactive as 
stimuli for pvrogen production. Theories of in vivo immune 
fever production are oroposed, on the basis of the present 
findings. 
. 
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